How should we measure the impact of chronic pain? Limitations of utility measurement using the EQ-5D and SF-6D

被引：6
|
作者：
Schofield, Deborah J. [1 ,2 ]
机构：
[1] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW 1450, Australia
[2] Univ Sydney, Sch Publ Hlth, Camperdown, NSW 1450, Australia
来源：
PAIN | 2014年 / 155卷 / 10期
关键词：
PREFERENCE-BASED MEASURE; HEALTH; PATIENT;
D O I：
10.1016/j.pain.2014.07.020
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：1918 / 1919
页数：2
相关论文
共 50 条
  • [41] Using the SF-6D to measure the impact of alcohol dependence on health-related quality of life
    Mosquera Nogueira, Jacinto
    Rodriguez-Miguez, Eva
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2015, 16 (04) : 347 - 356
  • [42] Mapping the neck disability index to SF-6D in patients with chronic neck pain
    Zheng, Yongjun
    Tang, Kun
    Ye, Le
    Ai, Zisheng
    Wu, Bin
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2016, 14
  • [43] COMMENT ON 'RESPONSE-SCALE HETEROGENEITY IN THE EQ-5D: CAN WE USE VIGNETTES TO ADDRESS RESPONSE-SCALE HETEROGENEITY IN THE EQ-5D? NOT IF BUT HOW'
    Robone, Silvana
    HEALTH ECONOMICS, 2017, 26 (03)
  • [44] Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes
    Al Sayah, Fatima
    Qiu, Weiyu
    Xie, Feng
    Johnson, Jeffrey A.
    QUALITY OF LIFE RESEARCH, 2017, 26 (08) : 2057 - 2066
  • [45] Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China
    Zhao, Longchao
    Liu, Xiang
    Liu, Danping
    He, Yan
    Liu, Zhijun
    Li, Ningxiu
    MEDICINE, 2019, 98 (11)
  • [46] A Head-to-Head Comparison of UK SF-6D and Thai and UK EQ-5D-5L Value Sets in Thai Patients with Chronic Diseases
    Sakthong, Phantipa
    Munpan, Wipaporn
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2017, 15 (05) : 669 - 679
  • [47] Predicting EQ-5D-US and SF-6D societal health state values from the Osteoporosis Assessment Questionnaire
    McDonough, C. M.
    Grove, M. R.
    Elledge, A. D.
    Tosteson, A. N. A.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 (02) : 723 - 732
  • [48] The SF-6Dv2: How Does the New Classification System Impact the Distribution of Responses Compared with the Original SF-6D?
    Whitehurst, David G. T.
    Brazier, John E.
    Viney, Rosalie
    Mulhern, Brendan J.
    PHARMACOECONOMICS, 2020, 38 (12) : 1283 - 1288
  • [49] How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer's disease?
    Reed, Catherine
    Barrett, Annabel
    Lebrec, Jeremie
    Dodel, Richard
    Jones, Roy W.
    Vellas, Bruno
    Wimo, Anders
    Maria Argimon, Josep
    Bruno, Giuseppe
    Maria Haro, Josep
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2017, 15
  • [50] Psychometric performance of the CFQ-R-8D compared to the EQ-5D-3L and SF-6D in people with cystic fibrosis
    Mukuria, Clara
    Rowen, Donna
    Acaster, Sarah
    McGarry, Lisa J.
    Lou, Yiyue
    Sosnay, Patrick R.
    Quittner, Alexandra L.
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2024, 8 (01)
12345